Get the Stockscreener App
1.48
1.37%
0.02
After Hours:
1.47
-0.01
-0.68%
Omniab Inc stock is traded at $1.48, with a volume of 672.63K.
It is up +1.37% in the last 24 hours and down -17.32% over the past month.
OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.
See More
Previous Close:
$1.46
Open:
$1.46
24h Volume:
672.63K
Relative Volume:
1.84
Market Cap:
$214.28M
Revenue:
$18.67M
Net Income/Loss:
$-64.78M
P/E Ratio:
-2.5654
EPS:
-0.5769
Net Cash Flow:
$-37.02M
1W Performance:
-2.63%
1M Performance:
-17.32%
6M Performance:
-13.45%
1Y Performance:
-21.69%
1-Day Range:
$1.44
$1.505
1-Week Range:
$1.43
$1.5651
52-Week Range:
$1.22
$2.295
Omniab Inc Stock (OABI) Company Profile
Name
Omniab Inc
Sector
Industry
Phone
510-250-7800
Address
5980 HORTON STREET, EMERYVILLE
Compare OABI vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OABI
Omniab Inc
|
1.48 | 211.38M | 18.67M | -64.78M | -37.02M | -0.5769 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Omniab Inc Stock (OABI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-29-23 | Initiated | RBC Capital Mkts | Outperform |
| Apr-21-23 | Initiated | The Benchmark Company | Buy |
| Apr-13-23 | Initiated | Craig Hallum | Buy |
| Feb-22-23 | Initiated | Cowen | Outperform |
| Feb-13-23 | Initiated | H.C. Wainwright | Buy |
| Dec-20-22 | Initiated | Truist | Buy |
| Dec-16-22 | Initiated | Credit Suisse | Outperform |
| Nov-29-22 | Initiated | SVB Leerink | Outperform |
| Nov-28-22 | Initiated | Stifel | Buy |
View All
Omniab Inc Stock (OABI) Latest News
OmniAb (OABI) well-positioned for momentum build-up in 2026 - MSN
Biotech Penny Stocks Rally OABI ABCL PACB 2026 - Gotrade
EBITDA per share of OmniAb, Inc. – NASDAQ:OABIW - TradingView — Track All Markets
Working capital per share of OmniAb, Inc. – NASDAQ:OABIW - TradingView — Track All Markets
Net current asset value per share of OmniAb, Inc. – NASDAQ:OABIW - TradingView — Track All Markets
OmniAb (OABI) Well-Positioned for Momentum Build-Up in 2026 - Yahoo Finance
Trade Report: Is Clearwater Paper Corporation attractive for institutional investorsQuarterly Growth Report & Weekly High Conviction Ideas - baoquankhu1.vn
Buy Signal: How correlated is OmniAb Inc to the S P5002026 Price Momentum & Smart Investment Allocation Insights - baoquankhu1.vn
OmniAb CFO Kurt Gustafson sells $10,300 in shares By Investing.com - Investing.com Canada
OmniAb director Foehr sells $29k in shares By Investing.com - Investing.com Canada
OmniAb (OABI) chief legal officer Berkman sells $10,663 in stock By Investing.com - Investing.com Canada
OmniAb CFO Sells Over $10,000 in Shares - National Today
OmniAb (NASDAQ:OABI) CEO Matthew Foehr Sells 19,244 Shares - MarketBeat
OmniAb (NASDAQ:OABI) Insider Sells $10,663.93 in Stock - MarketBeat
OmniAb (OABI) chief legal officer Berkman sells $10,663 in stock - Investing.com
OmniAb director Foehr sells $29k in shares - Investing.com
OmniAb CFO Kurt Gustafson sells $10,300 in shares - Investing.com
OABI Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Leerink reiterates Outperform on OmniAb stock, $10 target By Investing.com - Investing.com Australia
Leerink reiterates Outperform on OmniAb stock after partner trial fails - Investing.com UK
Leerink reiterates Outperform on OmniAb stock, $10 target - Investing.com UK
Leerink reiterates Outperform on OmniAb stock after partner trial fails By Investing.com - Investing.com Australia
Retail Trends: Should you avoid OmniAb Inc Equity Warrant stock right now2026 Geopolitical Influence & Proven Capital Preservation Tips - baoquankhu1.vn
Insider Buy: Whats the beta of OmniAb Inc Equity Warrant stockEarnings Performance Report & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK) and OmniAb (OABI) - The Globe and Mail
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Here Is Why You Should Not Ignore OmniAb Inc. (OABI) - insidermonkey.com
OmniAb (NASDAQ:OABI) Trading 3.3% HigherWhat's Next? - MarketBeat
Earnings Miss: What drives OmniAb Inc Equity Warrants stock price2026 Summary & Community Verified Trade Signals - baoquankhu1.vn
Truist reiterates OmniAb stock Buy rating on biotech recovery By Investing.com - Investing.com Australia
Truist reiterates OmniAb stock Buy rating on biotech recovery - Investing.com
Shorts Report: What analysts say about OmniAb Inc stock2026 Macro Moves & Verified Chart Pattern Trade Signals - baoquankhu1.vn
Nasdaq Moves: Will OmniAb Inc stock go up in YEAREarnings Performance Report & Smart Swing Trading Techniques - baoquankhu1.vn
Jobs Data: How correlated is OmniAb Inc to the S P5002026 Trade Ideas & Long-Term Growth Plans - baoquankhu1.vn
Market Outlook: What drives OmniAb Inc Equity Warrants stock priceWeekly Loss Report & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Quarterly Risk: Is OmniAb Inc Equity Warrant a stock for growth or value investors2026 Update & Capital Protection Trade Alerts - baoquankhu1.vn
Quarterly Risk: Can OmniAb Inc disrupt its industryTrade Risk Report & Free Risk Controlled Daily Trade Plans - baoquankhu1.vn
Aug Wrap: Will OmniAb Inc Equity Warrant benefit from rising consumer demand2026 Rallies & Precise Buy Zone Identification - baoquankhu1.vn
WOODSTOCK CORP's OmniAb Inc(OABI) Holding History - GuruFocus
If You Invested $1,000 in OmniAb, Inc. (OABI) - Stock Titan
Buyback Watch: What dividend growth rate does OmniAb Inc offer2026 Weekly Recap & Daily Chart Pattern Signal Reports - baoquankhu1.vn
OmniAb files to sell 21.25M shares of common stock for holders - MSN
History Review: What is OmniAb Incs market position2026 Market Mood & High Accuracy Trade Alerts - baoquankhu1.vn
Take Profit: Can TLRY stock double in the next yearMarket Activity Report & AI Enhanced Trade Execution Alerts - baoquankhu1.vn
Update Recap: Is OmniAb Inc stock undervalued right nowOptions Play & Short-Term Trading Alerts - baoquankhu1.vn
Aug Selloffs: Is OmniAb Inc Equity Warrant a stock for growth or value investorsWeekly Trend Summary & Stepwise Swing Trade Plans - baoquankhu1.vn
Investor Slashes $70 Million From Zymeworks as Stock Jumps 60% in a Year - AOL.com
Novanta Stock Has Underperformed This Past Year, but One Investor Just Made a $36 Million Bet on Shares - AOL.com
Tuniu (TOUR) Q4 2025 Earnings Call Transcript - AOL.com
OmniAb 2025 Growth: 107 Partners, 407 Programs, and New OmniUltra LaunchNews and Statistics - IndexBox
Omniab Inc Stock (OABI) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.69%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):